Key Takeaways
- • Congressman Steve Cohen announced $884,991 in NIH grants to St. Jude Children's Research Hospital across four awards, supporting cancer research, infectious disease training, and CAR T-cell implementation studies as of September 18, 2026.
- • The Trump administration is pursuing a sweeping overhaul of federal research grant allocation mechanisms, with White House budget director Russell Vought leading criticism of NIH funding practices and characterizing certain grants as "woke" research.
- • The Supreme Court has authorized the Trump administration to slash nearly $800 million in NIH research funding, creating potential pressure on the grant approval and distribution process.
- • Cohen's public support for NIH-funded cancer and biomedical research at St. Jude reflects potential friction between congressional leadership and the administration's proposed changes to federal research grant review and award procedures.
Summary
Congressman Steve Cohen (TN-9) announced on September 18, 2026, that St. Jude Children's Research Hospital would receive four grants totaling $884,991 from the National Institutes of Health. The award package spans multiple research domains: $263,328 from the National Institute of Allergy and Infectious Diseases for infectious disease therapeutics training; $289,458 from the National Cancer Institute for pediatric leukemia research; $49,114 for a predoctoral biomedical sciences program; and $283,091 for Real-World CAR T-cell implementation mapping. Cohen characterized the investment as foundational to improving patient outcomes, stating the grants would "result in better outcomes for patients and potentially save lives."
Concurrent with these grant announcements, the Trump administration is implementing a significant restructuring of how the federal government allocates billions in research funding. White House budget director Russell Vought has publicly criticized the NIH's grant distribution practices, with reporting indicating accusations that the agency funds "woke" research initiatives. This administrative pressure represents a material shift in the grant review landscape for research institutions.
The policy environment has further tightened following a Supreme Court decision authorizing the Trump administration to reduce NIH research funding by approximately $800 million. These dual pressures—administrative review of grant decisions and budget reductions—create uncertainty for the biomedical research funding ecosystem. Cohen's continued advocacy for specific NIH grants and his emphasis on cancer research outcomes suggest potential congressional-executive branch tension over research prioritization and the criteria governing federal grant awards to institutions like St. Jude.
Concurrent with these grant announcements, the Trump administration is implementing a significant restructuring of how the federal government allocates billions in research funding. White House budget director Russell Vought has publicly criticized the NIH's grant distribution practices, with reporting indicating accusations that the agency funds "woke" research initiatives. This administrative pressure represents a material shift in the grant review landscape for research institutions.
The policy environment has further tightened following a Supreme Court decision authorizing the Trump administration to reduce NIH research funding by approximately $800 million. These dual pressures—administrative review of grant decisions and budget reductions—create uncertainty for the biomedical research funding ecosystem. Cohen's continued advocacy for specific NIH grants and his emphasis on cancer research outcomes suggest potential congressional-executive branch tension over research prioritization and the criteria governing federal grant awards to institutions like St. Jude.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.